Evidence map›Paper›PMID 39904407›Full record

ArticleJournal of biomedical informatics2025

Evaluating the Bias, type I error and statistical power of the prior Knowledge-Guided integrated likelihood estimation (PIE) for bias reduction in EHR based association studies.

Naimin Jing, Yiwen Lu, Jiayi Tong, James Weaver, Patrick Ryan, Hua Xu, Yong Chen

Abstract read
In one paragraph

Article in Journal of biomedical informatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Naimin JingDepartment of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Yiwen LuCenter for Health AI and Synthesis of Evidence (CHASE), Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; The Graduate Group in Applied Mathematics and Computational Science, School of Arts and Sciences, University of Pennsylvania, Philadelphia, PA, USA.
Jiayi TongDepartment of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Center for Health AI and Synthesis of Evidence (CHASE), Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
James WeaverJanssen Research & Development, Titusville, NJ, USA.
Patrick RyanJanssen Research & Development, Titusville, NJ, USA.
Hua XuDepartment of Biomedical Informatics and Data Science, Yale University, New Haven, CT, USA.
Yong ChenDepartment of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Center for Health AI and Synthesis of Evidence (CHASE), Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; The Graduate Group in Applied Mathematics and Computational Science, School of Arts and Sciences, University of Pennsylvania, Philadelphia, PA, USA; Penn Institute for Biomedical Informatics (IBI), Philadelphia, PA, USA; Leonard Davis Institute of Health Economics, Philadelphia, PA, USA; Penn Medicine Center for Evidence-based Practice (CEP), Philadelphia, PA, USA. Electronic address: ychen123@pennmedicine.upenn.edu.

Funding

PANDA-MSD: Predictive Analytics via Networked Distributed Algorithms for Multi-System DiseasesU01TR003709 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI BIAN, JIANG, CHEN, YONG · 2022 to 2025
$4.7M
TRiPOD: Toward Reusable Phenotypes in Observational Data for AD/ADRD - managing definitions and correcting biasR01AG073435 · NIA · UNIVERSITY OF PENNSYLVANIA · PI CHEN, YONG, XU, HUA · 2021 to 2025
$3.9M
Dynamic learning for post-vaccine event prediction using temporal information in VAERSR01AI130460 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI CHEN, YONG, TAO, CUI · 2017 to 2021
$3.4M
ClinEX - Clinical Evidence Extraction, Representation, and AppraisalR01LM014344 · NLM · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Yong Chen, Yifan Peng · 2023 to 2026
$2.7M
AI-ADRD: Accelerating interventions of AD/ADRD via Machine learning methodsRF1AG077820 · NIA · UNIVERSITY OF PENNSYLVANIA · PI BIAN, JIANG, CHEN, YONG · 2023 to 2023
$2.3M
PheBC: bias correction methods for EHR derived phenotypeR01LM013519 · NLM · UNIVERSITY OF PENNSYLVANIA · PI CHEN, YONG, XU, HUA · 2021 to 2024
$1.6M
Advancing Drug Repositioning for Alzheimer’s Disease using Real-world DataR56AG069880 · NIA · UNIVERSITY OF FLORIDA · PI BIAN, JIANG, CHEN, YONG · 2021 to 2022
$1.6M
CICADA: clinical informatics and computational approaches for drug-repositioning of AD/ADRDR56AG074604 · NIA · UNIVERSITY OF PENNSYLVANIA · PI CHEN, YONG, TAO, CUI · 2021 to 2022
$1.5M
A General Framework to Account for Outcome Reporting Bias in Systematic ReviewsR01LM012607 · NLM · UNIVERSITY OF PENNSYLVANIA · PI CHEN, YONG · 2017 to 2020
$1.4M
Surrogate Augmented Deep Predictive Learning for Retinopathy of PrematurityR21EY034179 · NEI · UNIVERSITY OF PENNSYLVANIA · PI CHEN, YONG, HE, LIFANG · 2023 to 2023
$482k
Methods for Estimating Disease Burden of Seasonal InfluenzaR21AI167418 · NIAID · EMORY UNIVERSITY · PI CHANG, HOWARD H, CHEN, YONG · 2023 to 2024
$443k
NCATS NIH HHS U01 TR003709NEI NIH HHS R21 EY034179NIAID NIH HHS R01 AI130460NIAID NIH HHS R21 AI167418NIA NIH HHS R01 AG073435NIA NIH HHS R56 AG069880NIA NIH HHS R56 AG074604NIA NIH HHS RF1 AG077820NLM NIH HHS R01 LM012607NLM NIH HHS R01 LM013519NLM NIH HHS R01 LM014344
6 · The paper itself

Abstract

objectivesBinary outcomes in electronic health records (EHR) derived using automated phenotype algorithms may suffer from phenotyping error, resulting in bias in association estimation. Huang et al. [1] proposed the Prior Knowledge-Guided Integrated Likelihood Estimation (PIE) method to mitigate the estimation bias, however, their investigation focused on point estimation without statistical inference, and the evaluation of PIE therein using simulation was a proof-of-concept with only a limited scope of scenarios. This study aims to comprehensively assess PIE's performance including (1) how well PIE performs under a wide spectrum of operating characteristics of phenotyping algorithms under real-world scenarios (e. g., low prevalence, low sensitivity, high specificity); (2) beyond point estimation, how much variation of the PIE estimator was introduced by the prior distribution; and (3) from a hypothesis testing point of view, if PIE improves type I error and statistical power relative to the naïve method (i.e., ignoring the phenotyping error).

methodsSynthetic data and use-case analysis were utilized to evaluate PIE. The synthetic data were generated under diverse outcome prevalence, phenotyping algorithm sensitivity, and association effect sizes. Simulation studies compared PIE under different prior distributions with the naïve method, assessing bias, variance, type I error, and power. Use-case analysis compared the performance of PIE and the naïve method in estimating the association of multiple predictors with COVID-19 infection.

resultsPIE exhibited reduced bias compared to the naïve method across varied simulation settings, with comparable type I error and power. As the effect size became larger, the bias reduced by PIE was larger. PIE has superior performance when prior distributions aligned closely with true phenotyping algorithm characteristics. Impact of prior quality was minor for low-prevalence outcomes but large for common outcomes. In use-case analysis, PIE maintains a relatively accurate estimation across different scenarios, particularly outperforming the naïve approach under large effect sizes.

conclusionPIE effectively mitigates estimation bias in a wide spectrum of real-world settings, particularly with accurate prior information. Its main benefit lies in bias reduction rather than hypothesis testing. The impact of the prior is small for low-prevalence outcomes.

Indexed as

Electronic Health RecordsAlgorithmsBiasComputer SimulationCOVID-19HumansLikelihood FunctionsPhenotypeSARS-CoV-2Association studyBias reductionElectronic health recordPhenotyping error

Identifiers

PMID39904407
PMCPMC12180398

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.